ASSET
Published on ASSET (http://www.asset-scienceinsociety.eu)

Home > Glossary > Glossary

Glossary

A (34) | B (20) | C (59) | D (17) | E (40) | F (13) | G (26) | H (21) | I (28) | K (1) | L (8) | M (21) | N (8) | O (6) | P (42) | Q (3) | R (18) | S (53) | T (14) | U (9) | V (21) | W (3) | Z (1)
Definitionssort descending Last update
Vaccination 24/06/2015
Vaccination schedule 24/06/2015
Vaccine effectiveness 24/06/2015
Vaccine efficacy 24/06/2015
Vaccine failure 24/06/2015
Vaccine resistant groups 24/06/2015
Vaccines 24/06/2015
Validity 24/06/2015
Variola 24/06/2015
Vector 24/06/2015
Ventilator 24/06/2015
Vertical chain of communication 24/06/2015
Vibrio cholerae 24/06/2015
Viral 24/06/2015
Viral communication 24/06/2015
Viral hemorrhagic fever 24/06/2015
Viral replication 24/06/2015
Virulence 24/06/2015
Virulent 24/06/2015
Virus 24/06/2015
Vulnerability 24/06/2015

Newsletters

Select the newsletter(s) to which you want to subscribe or unsubscribe.

News from Asset project
Responsible Research and Innovation Newsletter
Asset PPRB
E-mail *

Contacts

Facebook
Twitter
YouTube
LinkedIn

Contacts

General inquiries: info@asset-scienceinsociety.eu

ASSET

Action plan on Science in Society related issues in Epidemics and Total pandemics
European Commission
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 612236.

Source URL: http://www.asset-scienceinsociety.eu/outputs/glossary/v